Prairie Operating repurchases $19M of Series F Preferred; issues Penny Warrants for up to 7M shares at $0.01

This filing

On April 8, 2026, Prairie Operating Co. (the "Company") entered into a letter agreement (the "Letter Agreement") with Hudson Bay PH XIX LLC ("High Trail")

Comparable filing

On May 6, 2026, Suja Life, Inc. (the “Company”) and Suja Life Holdings, L.P. (“Holdings LP”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC, Jefferies LLC, and William Blair & Company, L.L.C., as representatives of the several underwriters named therein (collectively, the “Underwriters”) relating to the initial public offering (the “IPO”) of the Company’s Class A common stock

This filing

On April 8, 2026, Prairie Operating Co. (the "Company") entered into a letter agreement (the "Letter Agreement") with Hudson Bay PH XIX LLC ("High Trail")

Comparable filing

In connection with the Private Placement, the Company entered into Registration Rights Agreements with the Investors, dated as of June 1, 2026 (the “PIPE Registration Rights Agreement”), pursuant to which the Company has agreed to (i) prepare and file a registration statement with the Securities and Exchange Commission (the “SEC”) covering the resale of the Common Stock sold in the Private Placement within 45 days of the closing of the Private Placement, (ii) use commercially reasonable efforts to have such registration statement declared effective within the time period set forth in the PIPE Registration Rights Agreement, and to keep such registration statement effective until the date that all registrable securities covered by such registration statement (a) have been sold, thereunder or pursuant to Rule 144, or (b) may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for 1 the Company to be in compliance with the current public i

This filing

On April 8, 2026, Prairie Operating Co. (the "Company") entered into a letter agreement (the "Letter Agreement") with Hudson Bay PH XIX LLC ("High Trail")

Comparable filing

A Share Rights Agreement, dated May 26, 2026, by and between the Company and Odyssey Transfer and Trust Company, as rights agent

This filing

On April 8, 2026, Prairie Operating Co. (the "Company") entered into a letter agreement (the "Letter Agreement") with Hudson Bay PH XIX LLC ("High Trail")

Comparable filing

pursuant to an additional securities purchase agreement with certain members of the executive management team of the Company (the “Management Purchase Agreement”

This filing

On April 8, 2026, Prairie Operating Co. (the "Company") entered into a letter agreement (the "Letter Agreement") with Hudson Bay PH XIX LLC ("High Trail")

Comparable filing

In connection with the Private Placement, on May 6, 2026, the Company and the Purchasers entered an Investor Rights Agreement.

This filing

On April 8, 2026, Prairie Operating Co. (the "Company") entered into a letter agreement (the "Letter Agreement") with Hudson Bay PH XIX LLC ("High Trail")

Comparable filing

Streeterville Series E Preferred Exchange Agreements On April 30, 2026, the Company entered into three Exchange Agreements (the “Exchanges”) with Streeterville.

This filing

On April 8, 2026, Prairie Operating Co. (the "Company") entered into a letter agreement (the "Letter Agreement") with Hudson Bay PH XIX LLC ("High Trail")

Comparable filing

On June 1, 2026, USA Rare Earth, Inc. (the “Company”) entered into a Lease Agreement (the “Lease”) with TC Liberty Development, LLC, a Delaware limited liability company (“Landlord”), for the lease of a to-be-constructed specialty rare earth magnet manufacturing facility located on Bear Den Road in Blacksburg, Cherokee County, South Carolina (the “Premises”).

This filing

On April 8, 2026, Prairie Operating Co. (the "Company") entered into a letter agreement (the "Letter Agreement") with Hudson Bay PH XIX LLC ("High Trail")

Comparable filing

On May 8, 2026, Nektar Therapeutics (the “Company”) entered into an Equity Distribution Agreement (the “Agreement”) with Guggenheim Securities, LLC (“Guggenheim Securities”) and H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which the Company may offer and sell, from time to time in its sole discretion, shares of its common stock, par value $0.0001 per share (the “Common Stock”) having an aggregate offering price of up to $150,000,000 (the “Shares”), through Guggenheim Securities and Wainwright as its sales agents.